Founder Drew Mihalyo launched the board with a mandate to move beyond passive support, tasking members with challenging the company’s development trajectory to ensure its tools provide tangible clinical utility. The group includes experts like Dr. Cory Chevalier and Dr. Jennifer Tjia, alongside technology strategist Vivek Dhayagude and AI executive Ernesto Lopez. Their collective focus will span clinical governance, data privacy, and the responsible integration of artificial intelligence into home-based care.
Since its introduction in March 2026, the platform has sought to unify disconnected health data—ranging from medication schedules and symptom tracking to connected-device inputs—into a single longitudinal record. By consolidating these disparate threads, the company hopes to provide families and caregivers with the continuity that standard medical episodes often miss. As the firm transitions into its next growth phase, the advisory board will provide the oversight necessary to align its digital infrastructure with the complex, human-centric needs of patients navigating chronic or serious health conditions.



Comments (0)
No comments yet. Be the first!